Lila Sciences is an artificial intelligence company headquartered in Cambridge, Massachusetts, pursuing what it terms scientific superintelligence: AI systems coupled with fully autonomous laboratories that can generate scientific hypotheses, design and execute experiments, and learn iteratively from real-world physical results across life, chemical and materials sciences.
The company was incubated within venture-creation firm Flagship Pioneering, the same organization behind Moderna. Lila's central thesis is that scientific progress can be dramatically accelerated by closing the loop between AI reasoning and automated wet-lab experimentation, rather than limiting AI to making predictions from pre-existing datasets.
Lila was founded in 2023. Geoffrey von Maltzahn serves as co-founder and CEO, with Flagship founder and CEO Noubar Afeyan as chairman, and Molly Gibson among the co-founding scientific leadership. The company is building both AI models and physical autonomous-lab infrastructure to pursue applications spanning therapeutics, novel materials and chemistry.
The company emerged from stealth in March 2025 with $200 million in seed capital led by Flagship Pioneering, joined by General Catalyst, March Capital and others including a subsidiary of the Abu Dhabi Investment Authority. It subsequently raised a $235 million Series A co-led by Collective Global and Braidwell at roughly a $1.23 billion valuation, followed by a roughly $115 million extension in October 2025 that included Nvidia's venture arm, bringing total capital to approximately $550 million at a valuation exceeding $1.3 billion.
Lila operates at the frontier of AI-for-science, an ambitious and capital-intensive category. Its strategy depends on demonstrating that autonomous labs paired with AI can produce validated scientific discoveries faster and more cheaply than traditional research, a high-risk, high-reward bet backed by some of the most prominent investors in deep tech.